M

    Myomo Inc (MYO)

    Official site

    HEALTHCARE • MEDICAL DEVICES • AMEX

    $1.50
    -0.09 (-5.94%)

    Market Cap: $63.37M

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    75%(27/36)
    Avg Surprise
    +13.18%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.07
    Range$-0.07 - $-0.07
    2 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$-0.07-7.1%
    60d ago$-0.08-14.3%
    30d ago$-0.08-14.3%
    7d ago$-0.08-14.3%
    Current$-0.07
    Revenue Consensus
    $11M
    Range$10M - $12M
    5 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.01
    Range$-0.01 - $-0.01
    2 analysts
    Revenue Consensus
    $14M
    Range$12M - $15M
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.01---
    Sep 26EST
    		-$-0.07---
    Jun 26
    Reported Aug 5
    		$-0.07$-0.10+30.00%Beat+36.4%
    Mar 26
    Reported May 7
    		$-0.09$-0.11+18.18%Beat-12.5%
    Dec 25
    Reported Mar 9
    		$-0.09$-0.08-1.43%Miss-752.0%
    Sep 25
    Reported Nov 10
    		$-0.09$-0.11+18.18%Beat-200.0%
    Jun 25
    Reported Aug 11
    		$-0.11$-0.11+0.00%Beat-266.7%
    Mar 25
    Reported May 7
    		$-0.08$-0.08+0.00%Beat+20.0%
    Dec 24
    Reported Mar 10
    		$-0.01N/A+57.08%Beat+85.7%
    Sep 24
    Reported Nov 6
    		$-0.03$-0.04+25.00%Beat+50.0%
    Jun 24
    Reported Aug 6
    		$-0.03N/A+57.14%Beat+25.0%
    Mar 24
    Reported May 8
    		$-0.10$-0.09-11.11%Miss+9.1%
    Dec 23
    Reported Mar 7
    		$-0.07$-0.06-16.67%Miss+75.9%
    Sep 23
    Reported Nov 7
    		$-0.06$-0.09+33.33%Beat+85.0%
    Jun 23
    Reported Aug 9
    		$-0.04$-0.03-33.33%Miss+90.5%
    Mar 23
    Reported May 10
    		$-0.11$-0.13+15.38%Beat+73.2%
    Dec 22
    Reported Mar 13
    		$-0.29$-0.42+30.95%Beat+44.2%
    Sep 22
    Reported Nov 10
    		$-0.40$-0.43+6.98%Beat-11.1%
    Jun 22
    Reported Aug 3
    		$-0.42$-0.43+2.33%Beat+8.7%
    Mar 22
    Reported May 11
    		$-0.41$-0.53+22.64%Beat+28.1%
    Dec 21
    Reported Mar 9
    		$-0.52$-0.49-6.12%Miss-40.5%
    Sep 21
    Reported Nov 10
    		$-0.36$-0.46+21.74%Beat+45.5%
    Jun 21
    Reported Aug 9
    		$-0.46$-0.61+24.59%Beat+54.9%
    Mar 21
    Reported May 5
    		$-0.57$-0.68+16.18%Beat+76.9%
    Dec 20
    Reported Mar 10
    		$-0.37$-0.49+24.49%Beat+92.0%
    Sep 20
    Reported Nov 10
    		$-0.66$-1.05+37.14%Beat+86.3%
    Jun 20
    Reported Aug 10
    		$-1.02$-1.34+23.88%Beat+77.3%
    Mar 20
    Reported May 14
    		$-2.47$-2.32-6.47%Miss+51.6%
    Dec 19
    Reported Mar 12
    		$-4.61$-4.59-0.44%Miss+29.2%
    Sep 19
    Reported Nov 12
    		$-4.80$-4.95+3.03%Beat+25.3%
    Jun 19
    Reported Aug 8
    		$-4.50$-5.10+11.76%Beat+29.2%
    Mar 19
    Reported May 13
    		$-5.10$-6.00+15.00%Beat+14.3%
    Dec 18
    Reported Mar 7
    		$-6.51$-7.50+13.20%Beat+9.6%
    Sep 18
    Reported Nov 5
    		$-6.43$-6.90+6.81%Beat-2.1%
    Jun 18
    Reported Aug 7
    		$-6.36$-5.40-17.78%Miss-2550.0%
    Mar 18
    Reported May 9
    		$-5.95$-5.70-4.39%Miss-
    Dec 17
    Reported Mar 7
    		$-7.20$-9.90+27.27%Beat-
    Sep 17
    Reported Nov 6
    		$-6.30$-9.00+30.00%Beat-
    Jun 17
    Reported Aug 14
    		$-0.24N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-4.49EV/EBITDA-0.82x
    Price/FCF-7.07xFCF Yield-14.14%
    Profitability
    Profit Margin-33.50%Operating Margin-19.30%
    ROE-123.80%ROIC-67.74%
    Financial Health
    Debt/Equity2.05xInterest CoverageN/A
    Current Ratio2.31xQuick Ratio2.01x
    Trading Statistics
    Beta1.44Avg Volume812.68K
    52-Week High$1.8952-Week Low$0.60

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.62
    SMA 20$1.51
    SMA 50$1.24
    SMA 200$0.98
    EMA 10$1.56
    EMA 20$1.49
    EMA 50$1.32
    EMA 200$1.26

    MACD

    Line: 0.11Signal: 0.13Hist: -0.02

    ADX

    ADX: 31.9+DI: 24.6-DI: 17.7

    Aroon & PSAR

    Aroon Up68.0
    Aroon Down8.0
    PSAR$1.78

    Bollinger Bands

    Upper Band$1.92
    Lower Band$1.10
    %B Position5395%(Upper)
    Band Width0.49

    RSI (14-Day)

    Neutral
    52.7

    Momentum Oscillators

    Stoch %K44.1
    Stoch %D48.4
    Williams %R-72.4
    ROC (10d)-4.1%
    Momentum-0.07
    CCI (20d)16.7
    MFI (14d)47.3

    Volatility Measures

    ATR (14d)$0.17(11.0%)
    StdDev (20d)0.20
    Hist Vol152.2%(High)

    Volume Flow

    VWAP$1.54
    OBV-24.0M
    AD Line-38.0M
    CMF (20d)0.215

    Volume Metrics

    Avg Vol (20d)838.2K
    Vol Ratio0.6x
    VWMA (20d)$1.53

    Pivot Points

    R3$1.74
    R2$1.70
    R1$1.65
    Pivot Point$1.61
    S1$1.56
    S2$1.52
    S3$1.47

    Advanced Oscillators

    TSI16.99
    Ultimate Osc50.6
    KST500.23

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$11.70M$10.11M$11.35M$10.09M$9.65M$9.83M$12.07M$9.21M$7.52M$3.75M$4.76M$5.08M
    Cost of Revenue$3.26M$3.21M$3.57M$3.65M$3.60M$3.22M$3.45M$2.26M$2.20M$1.46M$1.65M$1.59M
    Gross Profit$8.44M$6.90M$7.78M$6.44M$6.05M$6.61M$8.62M$6.95M$5.33M$2.30M$3.10M$3.49M
    Operating Expenses$10.70M$10.06M$10.56M$9.96M$10.64M$10.13M$8.86M$7.90M$6.44M$6.19M$5.54M$5.51M
    R&D$1.72M$1.62M$1.62M$1.53M$2.00M$1.79M$1.56M$1.25M$1.01M$956,215$878,005$717,256
    SG&A$3.71M$3.62M$3.43M$3.18M$3.41M$3.94M$3.60M$3.25M$2.66M$2.87M$2.31M$2.41M
    Operating Income$-2,254,486$-3,157,052$-2,773,759$-3,517,514$-4,590,320$-3,520,254$-245,314$-957,553$-1,115,064$-3,888,767$-2,433,209$-2,024,369
    Interest Income$-535,744$-504,696$-739,629$-9,743$106,549$191,991$70,031$76,020$107,242$135,293$108,221$112,300
    Interest Expense$1.74M$0$956,302$0$0$0$0$0$0$0$0$0
    Income Before Tax$-3,989,956$-2,822,684$-3,730,061$-3,527,257$-4,483,771$-3,328,263$-175,283$-881,533$-1,007,822$-3,753,474$-2,389,307$-1,982,660
    Income Tax Expense$31,404$186,715$83,878$135,658$148,201$136,795$84,798$84,876$113,785$82,158$70,797$46,356
    Net Income$-4,021,360$-3,009,399$-3,813,939$-3,662,915$-4,631,972$-3,465,058$-260,081$-966,409$-1,121,607$-3,835,632$-2,460,104$-2,029,016
    EBITDA$-2,656,691$-1,625,686$-1,693,497$-3,053,203$-4,142,503$-3,055,569$262,193$-845,856$-1,073,633$-3,849,477$-2,470,637$-1,896,680
    EBIT$-3,454,212$-2,317,988$-2,773,759$-3,517,514$-4,590,320$-3,520,254$-245,314$-957,553$-1,115,064$-3,888,767$-2,440,061$-2,023,902
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about MYO

    Government Contracts

    Gov Obligations (TTM)
    $789465
    Gov Obligations / Revenue
    1.9%
    Obligations YoY
    N/A
    Active Awards
    32
    New Awards (TTM)
    29
    Avg Remaining Term
    3.7 mo

    Top agency: Department of Veterans Affairs at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C26026P0578Department of Veterans AffairsDepartment of Veterans Affairs$31635May 19, 2026
    36C26226P1101Department of Veterans AffairsDepartment of Veterans Affairs$31635Jun 9, 2026
    36C25626P0719Department of Veterans AffairsDepartment of Veterans Affairs$31635May 26, 2026
    36C25026P0706Department of Veterans AffairsDepartment of Veterans Affairs$31635May 15, 2026
    36C24926P0311Department of Veterans AffairsDepartment of Veterans Affairs$31635Apr 15, 2026
    36C26026P0375Department of Veterans AffairsDepartment of Veterans Affairs$31635Mar 10, 2026
    36C25526P0144Department of Veterans AffairsDepartment of Veterans Affairs$31635Mar 30, 2026
    36C24826P0653Department of Veterans AffairsDepartment of Veterans Affairs$31635Mar 26, 2026
    36C26226P0680Department of Veterans AffairsDepartment of Veterans Affairs$31635Mar 18, 2026
    36C25026P0402Department of Veterans AffairsDepartment of Veterans Affairs$31635Mar 11, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Myomo to Present at the H.C. Wainwright 28th Annual Global Investment Conference

    Myomo, Inc. will participate in the H.C. Wainwright 28th Annual Global Investment Conference from September 14-16, 2026, in New York. The company's CEO, Paul Gudonis, and CFO, David Henry, will present and hold one-on-one meetings. Additionally, Mr. Gudonis and Mr. Henry will engage in a fireside chat with Sean Lee, Vice President of Equity Research, on September 16.

    Yahoo Finance•9/1/26•
    Somewhat-Bullish

    Myomo CMO Harry Kovelman sells $30,329 in stock

    Myomo Chief Medical Officer Harry Kovelman sold 17,500 shares of MYO stock for $30,329 on August 20, 2026, with shares trading between $1.72 and $1.75. This transaction follows a 164% surge in MYO stock over six months and comes after Myomo reported strong Q2 results, including a 21% revenue increase and a narrowed net loss, leading to a raised full-year sales outlook.

    Investing.com•8/24/26•
    Neutral

    Myomo CMO Harry Kovelman sells $30,329 in stock

    Harry Kovelman, Chief Medical Officer at MYOMO, INC. (NASDAQ:MYO), sold 17,500 shares of the company’s common stock for a total of $30,329. This transaction occurred on August 20, 2026, with shares sold at prices ranging from $1.72 to $1.75. The sale follows a significant 164% surge in MYO stock over the past six months and comes after the company reported strong Q2 financial results, including a 21% revenue increase and narrowed net loss.

    Investing.com•8/24/26•
    Neutral

    Myomo Chief Medical Officer Harry Kovelman sells 17,250 shares worth $29,891.98

    Myomo's Chief Medical Officer, Harry Kovelman, sold 17,250 common shares on August 20, 2026, for an average price of $1.73 per share, totaling $29,891.98. Following this transaction, Kovelman's holdings in the company decreased to 105,983 shares. This news brief was generated by AI using information originally published by Myomo Inc. via SEC EDGAR.

    Bitget•8/22/26•
    Neutral

    Myomo chief medical officer sells $29,895 in shares By Investing.com

    Myomo's Chief Medical Officer, Harry Kovelman, sold 17,250 shares of the company's common stock for approximately $29,895. This transaction occurred after the stock experienced a significant surge, increasing 136% over the past six months and 90% year-to-date. Despite the sale, Myomo recently reported strong Q2 financial results, exceeding revenue expectations and narrowing its net loss, leading to a raised full-year revenue outlook.

    Investing.com Nigeria•8/22/26•
    Neutral

    Frequently Asked Questions About MYO

    Does MYO pay dividends?
    Myomo Inc (MYO) does not currently pay a regular dividend.
    What is MYO's market cap?
    Myomo Inc (MYO) has a market capitalization of $63.37M with a current stock price of $1.50.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In